Literature DB >> 21937646

Cell-to-cell contact with hepatitis C virus-infected cells reduces functional capacity of natural killer cells.

Joo Chun Yoon1, Jong-Baeck Lim, Jeon Han Park, Jae Myun Lee.   

Abstract

The distinct feature of hepatitis C virus (HCV) infection is a high incidence of chronicity. The reason for chronic HCV infection has been actively investigated, and impairment of innate and adaptive immune responses against HCV is proposed as a plausible cause. Whereas functional impairment of HCV-specific T cells is well characterized, the role and functional status of natural killer (NK) cells in each phase of HCV infection are still elusive. We therefore investigated whether direct interaction between NK cells and HCV-infected cells modulates NK cell function. HCV-permissive human hepatoma cell lines were infected with cell culture-generated HCV virions and cocultured with primary human NK cells. Cell-to-cell contact between NK cells and HCV-infected cells reduced NK cells' capacity to degranulate and lyse target cells, especially in the CD56(dim) NK cell subset, which is characterized by low-density surface expression of CD56. The decrease in degranulation capacity was correlated with downregulated expression of NK cell-activating receptors, such as NKG2D and NKp30, on NK cells. The ability of NK cells to produce and secrete gamma interferon (IFN-γ) also diminished after exposure to HCV-infected cells. The decline of IFN-γ production was consistent with the reduction of NK cell degranulation. In conclusion, cell-to-cell contact with HCV-infected cells negatively modulated functional capacity of NK cells, and the inhibition of NK cell function was associated with downregulation of NK-activating receptors on NK cell surfaces. These observations suggest that direct cell-to-cell interaction between NK cells and HCV-infected hepatocytes may impair NK cell function in vivo and thereby contribute to the establishment of chronic infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21937646      PMCID: PMC3209413          DOI: 10.1128/JVI.00838-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C.

Authors:  J Nattermann; G Feldmann; G Ahlenstiel; B Langhans; T Sauerbruch; U Spengler
Journal:  Gut       Date:  2005-12-01       Impact factor: 23.059

2.  Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo.

Authors:  Katrin Wiemann; Hans-Willi Mittrücker; Ute Feger; Stefan A Welte; Wayne M Yokoyama; Thomas Spies; Hans-Georg Rammensee; Alexander Steinle
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

3.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.

Authors:  Takaji Wakita; Thomas Pietschmann; Takanobu Kato; Tomoko Date; Michiko Miyamoto; Zijiang Zhao; Krishna Murthy; Anja Habermann; Hans-Georg Kräusslich; Masashi Mizokami; Ralf Bartenschlager; T Jake Liang
Journal:  Nat Med       Date:  2005-06-12       Impact factor: 53.440

4.  Robust hepatitis C virus infection in vitro.

Authors:  Jin Zhong; Pablo Gastaminza; Guofeng Cheng; Sharookh Kapadia; Takanobu Kato; Dennis R Burton; Stefan F Wieland; Susan L Uprichard; Takaji Wakita; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

5.  Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas.

Authors:  Masahisa Jinushi; Tetsuo Takehara; Tomohide Tatsumi; Naoki Hiramatsu; Ryotaro Sakamori; Shinjiro Yamaguchi; Norio Hayashi
Journal:  J Hepatol       Date:  2005-06-29       Impact factor: 25.083

Review 6.  Activation, coactivation, and costimulation of resting human natural killer cells.

Authors:  Yenan T Bryceson; Michael E March; Hans-Gustaf Ljunggren; Eric O Long
Journal:  Immunol Rev       Date:  2006-12       Impact factor: 12.988

7.  Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I.

Authors:  Rhea Sumpter; Yueh-Ming Loo; Eileen Foy; Kui Li; Mitsutoshi Yoneyama; Takashi Fujita; Stanley M Lemon; Michael Gale
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

8.  Activation of natural killer cells during acute infection with hepatitis C virus.

Authors:  Barbara Amadei; Simona Urbani; Angelica Cazaly; Paola Fisicaro; Alessandro Zerbini; Parvin Ahmed; Gabriele Missale; Carlo Ferrari; Salim I Khakoo
Journal:  Gastroenterology       Date:  2010-01-18       Impact factor: 22.682

9.  Complete replication of hepatitis C virus in cell culture.

Authors:  Brett D Lindenbach; Matthew J Evans; Andrew J Syder; Benno Wölk; Timothy L Tellinghuisen; Christopher C Liu; Toshiaki Maruyama; Richard O Hynes; Dennis R Burton; Jane A McKeating; Charles M Rice
Journal:  Science       Date:  2005-06-09       Impact factor: 47.728

Review 10.  Natural killer cells as an initial defense against pathogens.

Authors:  Melissa B Lodoen; Lewis L Lanier
Journal:  Curr Opin Immunol       Date:  2006-06-12       Impact factor: 7.486

View more
  37 in total

1.  Monocytes activate natural killer cells via inflammasome-induced interleukin 18 in response to hepatitis C virus replication.

Authors:  Elisavet Serti; Jens M Werner; Michael Chattergoon; Andrea L Cox; Volker Lohmann; Barbara Rehermann
Journal:  Gastroenterology       Date:  2014-03-28       Impact factor: 22.682

Review 2.  Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells.

Authors:  Barbara Rehermann
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

Review 3.  Hepatitis C virus: life cycle in cells, infection and host response, and analysis of molecular markers influencing the outcome of infection and response to therapy.

Authors:  L B Dustin; B Bartolini; M R Capobianchi; M Pistello
Journal:  Clin Microbiol Infect       Date:  2016-08-31       Impact factor: 8.067

4.  Hepatitis C virus attenuates interferon-induced major histocompatibility complex class I expression and decreases CD8+ T cell effector functions.

Authors:  Wonseok Kang; Pil Soo Sung; Su-Hyung Park; Sarah Yoon; Dong-Yeop Chang; Seungtaek Kim; Kwang Hyub Han; Ja Kyung Kim; Barbara Rehermann; Yong-Joon Chwae; Eui-Cheol Shin
Journal:  Gastroenterology       Date:  2014-01-31       Impact factor: 22.682

5.  MicroRNA-155 regulates interferon-γ production in natural killer cells via Tim-3 signalling in chronic hepatitis C virus infection.

Authors:  Yong Q Cheng; Jun P Ren; Juan Zhao; Jia M Wang; Yun Zhou; Guang Y Li; Jonathan P Moorman; Zhi Q Yao
Journal:  Immunology       Date:  2015-04-21       Impact factor: 7.397

Review 6.  Natural killer cells in liver disease.

Authors:  Zhigang Tian; Yongyan Chen; Bin Gao
Journal:  Hepatology       Date:  2013-04       Impact factor: 17.425

7.  IFN-γ production by human natural killer cells in response to HCV-infected hepatoma cells is dependent on accessory cells.

Authors:  Shuye Zhang; Banishree Saha; Karen Kodys; Gyongyi Szabo
Journal:  J Hepatol       Date:  2013-05-07       Impact factor: 25.083

8.  Increased expressions of NKp44, NKp46 on NK/NKT-like cells are associated with impaired cytolytic function in self-limiting hepatitis E infection.

Authors:  Rumki Das; Anuradha Tripathy
Journal:  Med Microbiol Immunol       Date:  2014-05-14       Impact factor: 3.402

Review 9.  Natural killer cells in hepatitis C: Current progress.

Authors:  Joo Chun Yoon; Chang Mo Yang; Youkyong Song; Jae Myun Lee
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 10.  Natural killer cells: multifaceted players with key roles in hepatitis C immunity.

Authors:  Lucy Golden-Mason; Hugo R Rosen
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.